Eagle Meds Services
Inluriyo (imlunestrant)
Available to sourceHuman Prescription DrugDiabetes & Endocrine

Inluriyo (imlunestrant)

200 mg/1 · Film-Coated Tablet
By Eli Lilly and Company
NDC
0002-1717
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Estrogen Receptor Antagonist , Estrogen Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)NDC 0002-1717-28Available to order
  • 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)NDC 0002-1717-56Available to order
  • 56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)NDC 0002-1717-61Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Inluriyo (imlunestrant)
NDC 0002-1717